[EN] PYRAZOLOPYRIDINE DERIVATIVES AS ANTICANCER AGENT<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIDINE COMME AGENT ANTICANCER
申请人:PF MEDICAMENT
公开号:WO2011045344A1
公开(公告)日:2011-04-21
The present invention concerns compounds of following general formula (I): (Formula I) and their pharmaceutically acceptable salts, their method of preparation and their uses, notably as anticancer agent.
There are described pyrazolo[5.1-b]oxazole derivatives useful as corticotropin releasing factor (CRF
1
) receptor antagonists.
描述了作为促肾上腺皮质激素释放因子(CRF1)受体拮抗剂有用的吡唑并[5.1-b]噁唑衍生物。
CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID
申请人:Yu Chung-Shan
公开号:US20110306668A1
公开(公告)日:2011-12-15
A process for synthesizing and screening solution phase derived libraries of fenbufen and ethacrynic acid is provided in the present invention. Compounds in the present invention having cytotoxicities are useful for a variety of therapeutic applications.
A water-based composition for treating copper or copper alloy surface for lead-free soldering, the composition comprising a compound represented by general formula (1):
wherein R
1
is hydrogen or methyl, and either R
2
and R
3
represent chlorine and R
4
and R
5
represent hydrogen, or R
2
and R
3
represent hydrogen and R
4
and R
5
represent chlorine.
The invention provides novel deazaxanthine and deazahypoxanthine compounds. The compounds may be useful in the therapy of diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.